Clinical Trial Update: Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating mitoxantrone liposome combined with azacitidine for angioimmunoblastic T-cell lymphoma is in Phase 1/2, with status currently unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioimmunoblastic T-cell Lymphoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Mitoxantrone Liposome (mitoxantrone liposome)

Snippet

Sponsor: Huijing Wu | Conditions: Angioimmunoblastic T-cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN